These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 341133)

  • 1. Assessment of whole blood for antibody-dependent cell-mediated cytotoxicity in kidney patients.
    Dupont E
    Proc Eur Dial Transplant Assoc; 1977; 14():321-7. PubMed ID: 341133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-specific cell-mediated cytotoxicity in renal allograft recipients.
    Dickmeiss E
    Acta Pathol Microbiol Scand C; 1979 Dec; 87(6):371-76. PubMed ID: 397716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of allograft rejection.
    Williams GM
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):71-7. PubMed ID: 4612907
    [No Abstract]   [Full Text] [Related]  

  • 4. Steroid sensitivity of chronic uraemic and renal transplant patients measured by the antibody dependent cellular cytotoxicity reaction.
    Petri I; Csajbók E; Kiss E; Szenohradszky P; Kaiser G; Gál G
    Haematologia (Budap); 1985; 18(4):225-32. PubMed ID: 3915294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphocyte dependent antibody (LDA) test in renal transplanted patients.
    Wojtulewicz-Kurkus J; Podobińska I; Rowińska D; Lao M; Gutowska-Jablońska M; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):991-5. PubMed ID: 373697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody-dependent cell cytotoxicity and spontaneous cytotoxicity of peripheral blood lymphocytes of organ recipients and cells infiltrating the kidney allogeneic transplant].
    Drannik GN; Baran EIa; Seniuk OF; Driianskaia VE
    Fiziol Zh (1978); 1989; 35(5):68-72. PubMed ID: 2591583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of antibody dependent cellular cytotoxicity (ADCC). II. ADCC activity in renal graft recipients and acute accelerated graft rejection.
    Wasik M; Gradowska L; Lao M; Rowińska D; Orłowski T
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):311-4. PubMed ID: 373680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous cell-mediated cytotoxicity in humans. Distribution and characterization of the effector cell.
    Santoli D; Trinchieri G; Moretta L; Zmijewski CM; Koprowski H
    Clin Exp Immunol; 1978 Aug; 33(2):309-18. PubMed ID: 719952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic monitoring of the renal transplant recipient.
    Suthanthiran M; Garovoy MR
    Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of tests for cell mediated cytotoxicity in clinical kidney transplantation.
    Dickmeiss E
    Scand J Urol Nephrol Suppl; 1977; (42):51-4. PubMed ID: 356222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyses of histocompatibility in cadaver renal transplantation.
    Morris PJ
    Transplant Proc; 1971 Jun; 3(2):1030-5. PubMed ID: 4944045
    [No Abstract]   [Full Text] [Related]  

  • 13. Azathioprine suppression of natural killer activity and antibody-dependent cellular cytotoxicity in renal transplant recipients.
    Prince HE; Ettenger RB; Dorey FJ; Fine RN; Fahey JL
    Transplant Proc; 1984 Dec; 16(6):1475-7. PubMed ID: 6390849
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of antidonor antibody: advantages of fibroblast target cells.
    Halloran PF; Aprile M; Haddad G; Robinette M
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():49-55. PubMed ID: 386320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of immunological anti-donor reactivity in renal allotransplanted patients--a prospective study.
    Kristensen T; Grunnet N; Hansen HE; Fjeldborg O; Olsen S; Jørgensen F; Kissmeyer-Nielsen F
    Scand J Urol Nephrol Suppl; 1977; (42):46-50. PubMed ID: 356221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
    Warnatz H; Rösch W; Gerlich W; Gutmann W
    Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of azathioprine and prednisone in vivo treatment on lymphocyte-dependent antibody-mediated cytotoxicity (LDAC) in 57 human renal allograft recipients.
    Descamps B; Gagnon R; van Der Gaag R; Meyer O; Crosnier J
    Transplant Proc; 1977 Mar; 9(1):981-4. PubMed ID: 325832
    [No Abstract]   [Full Text] [Related]  

  • 19. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
    Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
    J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of rejection.
    Stiller CR; Sinclair NR
    Transplant Proc; 1979 Mar; 11(1):343-9. PubMed ID: 377654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.